Ashina, Messoud
Cohen, Joshua M.
Galic, Maja
Campos, Verena Ramirez
Barash, Steve
Ning, Xiaoping
Kessler, Yoel
Janka, Lindsay
Diener, Hans-Christoph
Funding for this research was provided by:
Teva Pharmaceuticals
Article History
Received: 16 March 2021
Accepted: 11 June 2021
First Online: 10 July 2021
Declarations
:
: This study was done in full accordance with the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Guidelines for Good Clinical Practice and any applicable national and local laws and regulations. All participants provided written informed consent before participation in the study. The final study protocol and informed consent form were reviewed and approved by an independent ethics committee or institutional review board at all participating study sites.
: Not applicable.
: MA has received personal fees from AbbVie/Allergan, Amgen, Eli Lilly, Lundbeck, Novartis, and Teva Pharmaceuticals. MA is the principal investigator for ongoing AbbVie/Allergan, Amgen and Lundbeck trials. MA has no ownership interest and does not own stocks of any pharmaceutical company. MA serves as associate editor of <i>Cephalalgia </i>and associate editor of <i>The Journal of Headache and Pain</i>. MA is president of the International Headache Society (IHS). JMC, MG, VRC, SB, XN, YK, and LJ are employees of Teva Pharmaceuticals. H-CD has received honoraria for participation in clinical trials, contribution to advisory boards, or oral presentations from Alder BioPharmaceuticals, Allergan, Amgen, electroCore, Ipsen, Eli Lilly, Medtronic, Novartis, Pfizer, Teva Pharmaceuticals, and Weber & Weber; electroCore provided financial support for research projects. H-CD has received research support from the German Research Council, the German Ministry of Education and Research, and the European Union. H-CD serves on the editorial boards of <i>Cephalalgia</i> and <i>The Lancet Neurology</i>. H-CD chairs the Clinical Guidelines Committee of the German Society of Neurology and is a member of the Clinical Trials Committee of the IHS.